Middle-term outcomes in renal transplant recipients with COVID-19: a national, multicenter, controlled study

被引:4
|
作者
Oto, Ozgur Akin [1 ]
Ozturk, Savas [1 ]
Arici, Mustafa [2 ]
Velioglu, Arzu [3 ]
Dursun, Belda [4 ]
Guller, Nurana [1 ]
Sahin, Idris [5 ]
Eser, Zeynep Ebru [6 ]
Paydas, Saime [7 ]
Trabulus, Sinan [8 ]
Koyuncu, Sumeyra [9 ]
Uyar, Murathan [10 ]
Ural, Zeynep [11 ]
Sadioglu, Rezzan Eren [12 ]
Dheir, Hamad [13 ]
Koc, Neriman Sila [2 ]
Ozer, Hakan [14 ]
Durak, Beyza Algul [15 ]
Gul, Cuma Bulent [16 ]
Kasapoglu, Umut [17 ]
Oguz, Ebru Gok [18 ]
Tanrisev, Mehmet [19 ]
Kuzgun, Gulsah Sasak [20 ]
Mirioglu, Safak [21 ]
Dervisoglu, Erkan [22 ]
Erken, Ertugrul [23 ]
Gorgulu, Numan [24 ]
Ozkurt, Sultan [25 ]
Aydin, Zeki [26 ]
Kurultak, ilhan [27 ]
Ogutmen, Melike Betul [28 ]
Bakirdogen, Serkan [29 ]
Kaya, Burcu [3 ]
Karadag, Serhat [30 ]
Ulu, Memnune Sena [31 ]
Gungor, Ozkan [23 ]
Bakir, Elif Ari [32 ]
Odabas, Ali Riza [33 ]
Seyahi, Nurhan [8 ]
Yildiz, Alaattin [1 ]
Ates, Kenan [12 ]
机构
[1] Istanbul Univ, Dept Internal Med, Div Nephrol, Istanbul Fac Med, Istanbul, Turkey
[2] Hacettepe Univ, Dept Nephrol, Fac Med, Ankara, Turkey
[3] Marmara Univ, Sch Med, Dept Internal Med, Div Nephrol, Istanbul, Turkey
[4] Pamukkale Univ, Fac Med, Dept Internal Med, Div Nephrol, Denizli, Turkey
[5] Inonu Univ, Fac Med, Dept Internal Med, Nephrol Div, Malatya, Turkey
[6] Mersin Univ, Mersin Fac Med, Dept Internal Med, Div Nephrol, Mersin, Turkey
[7] Cukurova Univ, Dept Internal Med, Div Nephrol, Fac Med, Adana, Turkey
[8] Istanbul Univ Cerrahpasa, Cerrahpasa Med Fac, Div Nephrol, Dept Internal Med, Istanbul, Turkey
[9] Erciyes Univ, Erciyes Fac Med, Dept Internal Med, Div Nephrol, Kayseri, Turkey
[10] Yeni Yuzyil Univ, Gaziosmanpasa Hosp, Div Nephrol, Dept Internal Med, Istanbul, Turkey
[11] Gazi Univ, Fac Med, Dept Internal Med, Div Nephrol, Ankara, Turkey
[12] Ankara Univ, Dept Nephrol, Sch Med, Ankara, Turkey
[13] Sakarya Univ Training & Res Hosp, Div Nephrol, Dept Internal Med, Sakarya, Turkey
[14] Konya Necmettin Erbakan Univ, Meram Fac Med, Div Nephrol, Konya, Turkey
[15] Ankara Bilkent City Hosp, Dept Nephrol, Ankara, Turkey
[16] Univ Hlth Sci, Bursa Yuksek Ihtisas Training & Res Hosp, Dept Nephrol, Istanbul, Turkey
[17] Univ Hlth Sci, Bakirkoy Dr Sadi Konuk Training & Res Hosp, Dept Nephrol, Istanbul, Turkey
[18] Univ Hlth Sci, Diskapi Yildirim Beyazit Educ & Res Hosp, Dept Nephrol, Ankara, Turkey
[19] Univ Hlth Sci, Tepecik Training & Res Hosp, Izmir Fac Med, Dept Nephrol, Izmir, Turkey
[20] Gortepe Prof Dr Suleyman Yalcin City Hosp, Dept Nephrol, Istanbul, Turkey
[21] Bezmialem Vakif Univ, Dept Internal Med, Div Nephrol, Sch Med, Istanbul, Turkey
[22] Kocaeli Univ, Fac Med, Dept Internal Med, Div Nephrol, Kocaeli, Turkey
[23] Kahramanmaras Sutcu Imam Univ, Dept Nephrol, Kahramanmaras, Turkey
[24] Univ Hlth Sci, Bagcilar Training & Res Hosp, Dept Nephrol, Istanbul, Turkey
[25] Eskisehir Osmangazi Univ, Fac Med, Dept Internal Med, Div Nephrol, Eskisehir, Turkey
[26] Univ Hlth Sci, Darica Farabi Training & Res Hosp, Dept Nephrol, Darica, Turkey
[27] Trakya Univ, Fac Med, Dept Internal Med, Div Nephrol, Edirne, Turkey
[28] Univ Hlth Sci, Haydarpasa Numune Training & Res Hosp, Dept Nephrol, Istanbul, Turkey
[29] Canakkale Onsekiz Mart Univ, Sch Med, Dept Internal Med, Div Nephrol, Canakkale, Turkey
[30] Univ Hlth Sci, Haseki Training & Res Hosp, Dept Nephrol, Istanbul, Turkey
[31] Bahcesehir Univ, Fac Med, Dept Internal Med, Div Nephrol, Istanbul, Turkey
[32] Univ Hlth Sci, Kartal Training Hosp, Dept Internal Med, Div Nephrol, Istanbul, Turkey
[33] Univ Hlth Sci, Sultan 2 Abdulhamid Han Training & Res Hosp, Dept Nephrol, Istanbul, Turkey
关键词
COVID-19; kidney transplantation; mortality; outcome; registry;
D O I
10.1093/ckj/sfac045
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background In this study, we evaluated 3-month clinical outcomes of kidney transplant recipients (KTR) recovering from COVID-19 and compared them with a control group. Method The primary endpoint was death in the third month. Secondary endpoints were ongoing respiratory symptoms, need for home oxygen therapy, rehospitalization for any reason, lower respiratory tract infection, urinary tract infection, biopsy-proven acute rejection, venous/arterial thromboembolic event, cytomegalovirus (CMV) infection/disease and BK viruria/viremia at 3 months. Results A total of 944 KTR from 29 different centers were included in this study (523 patients in the COVID-19 group; 421 patients in the control group). The mean age was 46 +/- 12 years (interquartile range 37-55) and 532 (56.4%) of them were male. Total number of deaths was 8 [7 (1.3%) in COVID-19 group, 1 (0.2%) in control group; P = 0.082]. The proportion of patients with ongoing respiratory symptoms [43 (8.2%) versus 4 (1.0%); P Conclusion The prevalence of ongoing respiratory symptoms increased in the first 3 months post-COVID in KTRs who have recovered from COVID-19, but mortality was not significantly different.
引用
收藏
页码:999 / 1006
页数:8
相关论文
共 50 条
  • [21] Characteristics of COVID-19 Disease in Renal Transplant Recipients
    Zimnickaite, Emilija
    Kucinaite, Ieva
    Zablockiene, Birute
    Lisinskaite, Aiste
    Zablockis, Rolandas
    Rimsevicius, Laurynas
    Miglinas, Marius
    Jancoriene, Ligita
    MEDICINA-LITHUANIA, 2024, 60 (02):
  • [22] COVID-19 vaccine hesitancy in renal transplant recipients
    Basic-Jukic, Nikolina
    Furic-Cunko, Vesna
    Jelakovic, Bojan
    THERAPEUTIC APHERESIS AND DIALYSIS, 2022, 26 (02) : 482 - 483
  • [23] COVID-19 Infections in Pediatric Renal Transplant Recipients
    Yilmaz, Aysun Caltik
    Baskin, Esra
    Gulleroglu, Kaan
    Karakaya, Deniz
    Akdur, Aydincan
    Moray, Gokhan
    Haberal, Mehmet
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2022, 20 (03) : 156 - 160
  • [24] COVID-19 Infections in Pediatric Renal Transplant Recipients
    Yilmaz, Aysun Caltik
    Baskin, Esra
    Gulleroglu, Kaan
    Akdur, Aydincan
    Moray, Gokhan
    Haberal, Mehmet
    TRANSPLANTATION, 2022, 106 (09) : S181 - S181
  • [25] COVID-19 in kidney transplant recipients: A multicenter experience in Istanbul
    Demir, Erol
    Uyar, Murathan
    Parmaksiz, Ergun
    Sinangil, Ayse
    Yelken, Berna
    Dirim, Ahmet Burak
    Merhametsiz, Ozgur
    Yadigar, Serap
    Atan Ucar, Zuhal
    Ucar, Ali Riza
    Demir, Mehmet Emin
    Mese, Meral
    Akin, Emin Baris
    Garayeva, Nurana
    Safak, Seda
    Oto, Ozgur Akin
    Yazici, Halil
    Turkmen, Aydin
    TRANSPLANT INFECTIOUS DISEASE, 2020, 22 (05)
  • [26] Outcomes After Covid-19 Infection in Transplant Recipients
    Freels, K. L.
    Saharia, K.
    Baddley, J.
    Costa, N.
    Niederhaus, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 761 - 762
  • [27] Outcomes of COVID-19 infection in heart transplant recipients
    Miklin, D.
    Mantha, A.
    Wolfson, A.
    Vaidya, A.
    Depasquale, E.
    EUROPEAN HEART JOURNAL, 2021, 42 : 964 - 964
  • [28] Covid-19 hospitalization among liver transplant recipients: Multicenter study of clinical outcomes in the United States.
    Gottlieb, Robert L.
    Chandak, Aastha
    Chen, Linda
    Jiang, Heng
    Kwon, Kyung min
    Frenette, Catherine
    Mozaffari, Essy
    TRANSPLANTATION, 2024, 108 (9S)
  • [29] COVID-19 Outcomes in Kidney Transplant Recipients in a German Transplant Center
    Mikhailov, Michael
    Budde, Klemens
    Halleck, Fabian
    Eleftheriadis, Georgios
    Naik, Marcel G.
    Schrezenmeier, Eva
    Bachmann, Friederike
    Choi, Mira
    Duettmann, Wiebke
    von Hoerschelmann, Ellen
    Koch, Nadine
    Liefeldt, Lutz
    Luecht, Christian
    Straub-Hohenbleicher, Henriette
    Waiser, Johannes
    Weber, Ulrike
    Zukunft, Bianca
    Osmanodja, Bilgin
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (18)
  • [30] COVID-19 in Lung Transplant Recipients: Outcomes and Long-Term Follow Up
    Hallak, R. H.
    Wolfe, C. R.
    Reynolds, J. M.
    Koweek, L. M.
    McAdams, H.
    Ali, H. Azfar
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S527 - S527